Private Equity

Updated:

Wanxiang Healthcare Investments

Wanxiang Healthcare Investments is a corporate-backed venture group focused on healthcare technologies, particularly digital health. The firm invests in seed...

Wanxiang Healthcare Investments logo

Wanxiang Healthcare Investments

Wanxiang Healthcare Investments is a corporate-backed venture group focused on healthcare technologies, particularly digital health. The firm invests in seed and growth rounds. It has made 17 investments, including a Series B investment in Watershed Health on May 14, 2024.

General information

Firm type

Private Equity

Location

Region

North America

Country

United States

City

Elgin

Corporate office

Elgin, IL, United States

Sector focus

Healthcare ServicesDigital HealthMedical DevicesBiotechnology

Frequently asked questions

What is Wanxiang Healthcare Investments' investment mandate?

The firm runs a healthcare-exclusive strategy that spans seed, start-up, and growth stages. Its mandate covers biotech, medical devices, diagnostics, and healthcare IT — essentially the full spectrum of innovation-driven healthcare subsectors. Wanxiang participates in both venture and growth equity rounds, giving it a stage-agnostic posture uncommon among specialized healthcare funds.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Elgin Private Equity profiles